Opus Genetics IRD Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's accounts payable?
- Opus Genetics (IRD) reported accounts payable of $1.16M in Q1 2026.
- How has Opus Genetics's accounts payable changed year-over-year?
- Opus Genetics's accounts payable increased by 260.9% year-over-year, from -$718K to $1.16M.
- What is the long-term trend for Opus Genetics's accounts payable?
- Over 2 years (2022 to 2025), Opus Genetics's accounts payable has grown at a -88.3% compound annual growth rate (CAGR), from -$515K to $7K.
- What does accounts payable mean?
- Represents the net change in obligations owed to suppliers and vendors for goods and services received during the period. This metric reflects the company's short-term liquidity management and its ability to negotiate payment terms with trade creditors.